Showing results (1881-1890 of 1,914) with videos related to

Sort By:
Pageof 192
Bioorganic & Medicinal Chemistry|March 6, 2009
Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitorsTing-Yueh Tsai, Tsu Hsu, Chiung-Tong Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2010
(2S,4S)-1-[2-(1,1-dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IVTeng-Kuang Yeh, Ting-Yueh Tsai, Tsu Hsu, et al.
JAMA Network Open|May 1, 2023
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance DialysisHaitao Zhang, Guisen Li, Xueqing Yu, et al.
Genetic Epidemiology|November 10, 2022
Multivariate analysis of a missense variant in CREBRF reveals associations with measures of adiposity in people of Polynesian ancestriesJerry Z Zhang, Lacey W Heinsberg, Mohanraj Krishnan, et al.
The Journal of Biological Chemistry|November 14, 2014
Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small moleculeGejing Deng, Junqing Shen, Ming Yin, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Zhonghua Yi Xue Za Zhi|July 12, 2012
[Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]Fu-lian Hu, Hong Cheng, Xue-zhi Zhang, et al.
Current Medical Research and Opinion|April 20, 2018
Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort studyZhi-Hong Liu, Xue-Qing Yu, Jun-Wei Yang, et al.
HGG Advances|November 7, 2022
A stop-gain variant in <i>BTNL9</i> is associated with atherogenic lipid profilesJenna C Carlson, Mohanraj Krishnan, Samantha L Rosenthal, et al.
The Journal of Pathology|July 12, 2017
Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virusWen-Chun Liu, I-Chin Wu, Yen-Chien Lee, et al.
Pageof 192